ResMed, Inc. (RSMDF)
19.66
0.00 (0.00%)
USD |
OTCM |
Apr 06, 16:00
ResMed Market Cap : 28.79B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 176.75B |
| Accuray, Inc. | 50.21M |
| Alphatec Holdings, Inc. | 1.683B |
| Boston Scientific Corp. | 92.51B |
| Plus Therapeutics, Inc. | 21.37M |
Market Cap Related Metrics
| PE Ratio | 19.43 |
| PS Ratio | 5.350 |
| PEG Ratio | 0.9957 |
| Price to Book Value | 4.554 |
| Price to Free Cash Flow | 15.91 |
| Price | 19.66 |
| Earnings Yield | 5.15% |
| PEGY Ratio | 0.9957 |
| Operating PE Ratio | 15.65 |
| Normalized PE Ratio | 19.24 |